3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
NIH
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Gastrointestinal
1
Conditions
Multiple Myeloma
420
Lymphoma, Large B-Cell, Diffuse
93
Leukemia, Lymphocytic, Chronic, B-Cell
88
Lymphoma, Follicular
79
Recurrence
68
Lymphoma
60
Neoplasms, Plasma Cell
57
Lymphoma, Mantle-Cell
56
Lymphoma, B-Cell, Marginal Zone
47
Lymphoma, Non-Hodgkin
46
Leukemia, Myeloid, Acute
34
Leukemia
32
Lymphoma, B-Cell
24
Neoplasms
23
Myelodysplastic Syndromes
23
Waldenstrom Macroglobulinemia
18
Hodgkin Disease
18
Smoldering Multiple Myeloma
17
Lymphoma, T-Cell, Peripheral
16
Burkitt Lymphoma
14
Hematologic Diseases
13
Lymphoma, T-Cell, Cutaneous
12
Lymphoma, T-Cell
12
Prostatic Neoplasms
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Sezary Syndrome
10
Mycosis Fungoides
10
Lymphoma, Large-Cell, Anaplastic
9
Leukemia, Myelomonocytic, Chronic
9
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
8
Interventions
Cisplatin
16
Cetuximab
16
Radiotherapy, Intensity-Modulated
10
Radiotherapy
7
Docetaxel
7
Fluorouracil
5
Erlotinib Hydrochloride
5
Everolimus
4
Carboplatin
4
Sorafenib
3
Paclitaxel
3
Fluorodeoxyglucose F18
3
Chemotherapy, Adjuvant
3
Albumin-Bound Paclitaxel
3
130-nm albumin-bound paclitaxel
3
Ultrasonography
2
Taxes
2
Sirolimus
2
Radiotherapy, Conformal
2
Radiation
2
Platinum
2
Photochemotherapy
2
Magnetic Resonance Spectroscopy
2
Cryosurgery
2
Celecoxib
2
Biopsy
2
Bevacizumab
2
1-phenyl-3,3-dimethyltriazene
2
1,2-diaminocyclohexaneplatinum II citrate
2
temsirolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Tongue Neoplasms
×
Lenalidomide
×
Clear all
NCT01254617
2020-03-13
ADCC
National Cancer Institute (NCI)
Phase 1
Completed
24 enrolled